- Filed
- Apr 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 31, 2025 | 1.23B sh |
| Cash And Equivalents | Q3 2025 · Feb 28, 2025 | $16.4M |
| Cash And Equivalents | Q3 2025 · May 31, 2024 | $3.11M |
| Cash And Equivalents | Q3 2025 · Feb 29, 2024 | $1.4M |
| Current Liabilities | Q3 2025 · Feb 28, 2025 | $70.57M |
| Current Liabilities | Q3 2025 · May 31, 2024 | $84.18M |
| Total Liabilities | Q3 2025 · Feb 28, 2025 | $114.17M |
| Total Liabilities | Q3 2025 · May 31, 2024 | $127.89M |
| Current Assets | Q3 2025 · Feb 28, 2025 | $20.98M |
| Current Assets | Q3 2025 · May 31, 2024 | $10.82M |
| Total Assets | Q3 2025 · Feb 28, 2025 | $21.19M |
| Total Assets | Q3 2025 · May 31, 2024 | $11.14M |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 982.21M sh |
| Shares Diluted | Q3 2025 · Feb 29, 2024 | 954.81M sh |
| Operating Cash Flow | Q3 2025 · Feb 29, 2024 | −$9.33M |
| Stockholders Equity | Q3 2025 · Feb 29, 2024 | −$119.38M |
| Stockholders Equity | Q3 2025 · Nov 30, 2023 | −$114.38M |
| Stockholders Equity | Q3 2025 · Aug 31, 2023 | −$116.89M |
| Stockholders Equity | Q3 2025 · May 31, 2023 | −$109.5M |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | −$0.01 |
| Eps Diluted | Q3 2025 · Feb 29, 2024 | −$0.04 |
| Eps Basic | Q3 2025 · Feb 29, 2024 | −$0.01 |
| Eps Basic | Q3 2025 · Feb 29, 2024 | −$0.04 |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $2.76M |
| Sga Expense | Q3 2025 · Feb 29, 2024 | $7.76M |
| Net Income | Q3 2025 · Feb 29, 2024 | −$11.92M |
| Net Income | Q3 2025 · Feb 29, 2024 | −$33.05M |
| Net Income | Q3 2025 · Nov 30, 2023 | −$9.56M |
| Net Income | Q3 2025 · Aug 31, 2023 | −$11.57M |
| Operating Income | Q3 2025 · Feb 29, 2024 | −$3.41M |
| Operating Income | Q3 2025 · Feb 29, 2024 | −$11.42M |